Henry Schein

HSIC

Market cap $9.7B

Henry Schein, Inc. (HSIC) Q4 2025 Earnings Call Transcript

Global Distribution and Value-Added Services sales rose 7.0% to $2.89 billion in the fourth quarter, up 5.2% on a constant-currency basis from the year-ago period.

The headline numbers for Henry Schein (HSIC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Henry Schein tops Q4 estimates with 7.8% sales growth, but margin contraction tempers strong equipment, specialty and tech gains.

Henry Schein on Tuesday beat fourth-quarter profit estimates and forecast annual profit largely in line with Wall Street expectations on the back of stabilizing demand for its dental and medical equipment.

Henry Schein (HSIC) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.3 per share. This compares to earnings of $1.19 per share a year ago.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the fourth quarter ended December 27, 2025. “Our fourth-quarter sales reflect continuing momentum resulting in the highest sales growth in 15 quarters. We are pleased with the sales results across all our businesses, particularly our global equipment, specialty products and technology busi.

AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One, the market leader in dental practice management systems, today announced the launch of AI-driven Image Verify, the latest innovation in a rapid series of product advancements designed to deliver the cleanest claims experience in dentistry. Image Verify, natively embedded in Dentrix and Dentrix Ascend, represents another major step towards the company's bold Clean Claims vision – a future where dental practices submit claims once and never.

Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HSIC gears up for Q4 results, with revenues seen rising 4.5% and strength across dental, medical and tech segments shaping expectations.